Ubiquitin and Ubiquitin-Like Proteins Are Essential Regulators of DNA Damage Bypass.
Ubiquitin and Ubiquitin-Like Proteins Are Essential Regulators of DNA Damage Bypass.
复制标题
泛素和泛素样蛋白是DNA损伤旁路的重要调节因子。
DOI:
10.3390/cancers12102848
复制
发表时间:
2020-10-02
期刊:
影响因子:
5.2
通讯作者:
Woodgate R
中科院分区:
文献类型:
--
作者:
Wilkinson NA;Mnuskin KS;Ashton NW;Woodgate R
Ubiquitin and ubiquitin-like proteins are conjugated to many other proteins within the cell, to regulate their stability, localization, and activity. These modifications are essential for normal cellular function and the disruption of these processes contributes to numerous cancer types. In this review, we discuss how ubiquitin and ubiquitin-like proteins regulate the specialized replication pathways of DNA damage bypass, as well as how the disruption of these processes can contribute to cancer development. We also discuss how cancer cell survival relies on DNA damage bypass, and how targeting the regulation of these pathways by ubiquitin and ubiquitin-like proteins might be an effective strategy in anti-cancer therapies. Many endogenous and exogenous factors can induce genomic instability in human cells, in the form of DNA damage and mutations, that predispose them to cancer development. Normal cells rely on DNA damage bypass pathways such as translesion synthesis (TLS) and template switching (TS) to replicate past lesions that might otherwise result in prolonged replication stress and lethal double-strand breaks (DSBs). However, due to the lower fidelity of the specialized polymerases involved in TLS, the activation and suppression of these pathways must be tightly regulated by post-translational modifications such as ubiquitination in order to limit the risk of mutagenesis. Many cancer cells rely on the deregulation of DNA damage bypass to promote carcinogenesis and tumor formation, often giving them heightened resistance to DNA damage from chemotherapeutic agents. In this review, we discuss the key functions of ubiquitin and ubiquitin-like proteins in regulating DNA damage bypass in human cells, and highlight ways in which these processes are both deregulated in cancer progression and might be targeted in cancer therapy.
登录
查看更多内容
影响因子:
6.4
作者:
Arbel, Matan;Bronstein, Alex;Kupiec, Martin
通讯作者:
Kupiec, Martin
影响因子:
5.3
作者:
Chiolo, Irene;Saponaro, Marco;Liberi, Giordano
通讯作者:
Liberi, Giordano
DOI:
10.1016/j.mrfmmm.2006.01.003
发表时间:
2006-07-25
影响因子:
2.3
作者:
Choi, Jun-Hyuk;Besaratinia, Ahmad;Pfeifer, Gerd P.
通讯作者:
Pfeifer, Gerd P.
影响因子:
14.9
作者:
Burkovics P;Dome L;Juhasz S;Altmannova V;Sebesta M;Pacesa M;Fugger K;Sorensen CS;Lee MY;Haracska L;Krejci L
通讯作者:
Krejci L
影响因子:
11.2
作者:
Albertella, MR;Green, CM;O'Connor, MJ
通讯作者:
O'Connor, MJ